|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/09 | (2006.01) |
| A61K 39/385 | (2013.01) | ||
| A61K 39/385 | (2006.01) | ||
| A61K2039/55544 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K2039/58 | (2013.01) | ||
| A61K2039/70 | (2013.01) | ||
| A61K 39/092 | (2013.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 37/04 | (2018.01) |
| (11) | Number of the document | 3244917 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16702585.7 |
| Date of filing the European patent application | 2016-01-05 | |
| (97) | Date of publication of the European application | 2017-11-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/050036 |
| Date | 2016-01-05 |
| (87) | Number | WO 2016/113644 |
| Date | 2016-07-21 |
| (30) | Number | Date | Country code |
| 201562103630 P | 2015-01-15 | US |
| (72) |
COOPER, David , US
JANSEN, Kathrin Ute , US
PRIDE, Michael William , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES |
| IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES |